These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2475929)

  • 1. Inactivation of the human immunodeficiency viruses (HIV-1 and HIV-2) during the manufacturing of placental albumin and gammaglobulins.
    Grandgeorge M; Pelloquin F
    Transfusion; 1989 Sep; 29(7):629-34. PubMed ID: 2475929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Validation of the virus inactivation capacity of a procedure of human plasma albumin purification by chromatography].
    Stoltz JF; Geschier C; Rivat C; Sertillanges P; Grandgeorges M; Liautaud J; Regnault V; Dumont L
    Ann Pharm Fr; 1993; 51(2):78-93. PubMed ID: 8250488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral validation of the manufacturing process of high purity albumin from placentas.
    Grandgeorge M; Véron JL
    Dev Biol Stand; 1993; 81():237-44. PubMed ID: 8174808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological Safety of a Highly Purified 10% Liquid Intravenous Immunoglobulin Preparation from Human Plasma.
    Goussen C; Simoneau S; Bérend S; Jehan-Kimmel C; Bellon A; Ducloux C; You B; Paolantonacci P; Ollivier M; Burlot L; Chtourou S; Flan B
    BioDrugs; 2017 Jun; 31(3):251-261. PubMed ID: 28508264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogen Safety of a New Intravenous Immune Globulin 10% Liquid.
    Radomski KU; Lattner G; Schmidt T; Römisch J
    BioDrugs; 2017 Apr; 31(2):125-134. PubMed ID: 28236170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Viral safety of Nanogam, a new 15 nm-filtered liquid immunoglobulin product.
    Terpstra FG; Parkkinen J; Tölö H; Koenderman AH; Ter Hart HG; von Bonsdorff L; Törmä E; van Engelenburg FA
    Vox Sang; 2006 Jan; 90(1):21-32. PubMed ID: 16359352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatographic removal and heat inactivation of hepatitis A virus during manufacture of human albumin.
    Adcock WL; MacGregor A; Davies JR; Hattarki M; Anderson DA; Goss NH
    Biotechnol Appl Biochem; 1998 Aug; 28(1):85-94. PubMed ID: 9693093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromatographic removal and heat inactivation of hepatitis B virus during the manufacture of human albumin.
    Adcock WL; MacGregor A; Davies JR; Hattarki M; Anderson DA; Goss NH
    Biotechnol Appl Biochem; 1998 Oct; 28 ( Pt 2)():169-78. PubMed ID: 9756468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus reduction in the preparation of intravenous immune globulin: in vitro experiments.
    Chandra S; Cavanaugh JE; Lin CM; Pierre-Jerome C; Yerram N; Weeks R; Flanigan E; Feldman F
    Transfusion; 1999 Mar; 39(3):249-57. PubMed ID: 10204586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternatives for plasma fractionation.
    Schneider W; Wolter D; McCarty LJ
    Vox Sang; 1976; 31(2):141-51. PubMed ID: 60002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion-removal capacity of chromatographic and ethanol precipitation steps used in the production of albumin and immunoglobulins.
    Thyer J; Unal A; Thomas P; Eaton B; Bhashyam R; Ortenburg J; Uren E; Middleton D; Selleck P; Maher D
    Vox Sang; 2006 Nov; 91(4):292-300. PubMed ID: 17105604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Absence of prostaglandins in serum albumins and gammaglobulins from placental blood].
    Quattroccolo M; Hein C; Plan R
    Dev Biol Stand; 1974; 27():200-4. PubMed ID: 4142773
    [No Abstract]   [Full Text] [Related]  

  • 13. Inactivation of viral and prion pathogens by gamma-irradiation under conditions that maintain the integrity of human albumin.
    Miekka SI; Forng RY; Rohwer RG; MacAuley C; Stafford RE; Flack SL; MacPhee M; Kent RS; Drohan WN
    Vox Sang; 2003 Jan; 84(1):36-44. PubMed ID: 12542732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of the major plasma fractions by solid-phase polyelectrolytes.
    Johnson AJ; MacDonald VE; Semar M; Fields JE; Schuck JC; Brind J
    J Lab Clin Med; 1978 Aug; 92(2):194-210. PubMed ID: 79628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of virus in intravenous immunoglobulin G using solvent/detergent treatment and pasteurization.
    Aghaie A; Pourfatollah AA; Bathaie SZ; Moazzeni SM; Khorsand Mohammad Pour H; Sharifi Z
    Hum Antibodies; 2008; 17(3-4):79-84. PubMed ID: 19029665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral safety characteristics of Flebogamma DIF, a new pasteurized, solvent-detergent treated and Planova 20 nm nanofiltered intravenous immunoglobulin.
    Caballero S; Nieto S; Gajardo R; Jorquera JI
    Biologicals; 2010 Jul; 38(4):486-93. PubMed ID: 20350815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis B: Au/HA-antigen during production of human albumin and gammaglobulin.
    Chariatte N
    Dev Biol Stand; 1974; 27():166-71. PubMed ID: 4142770
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific inactivation of viruses which can potentially contaminate blood products.
    Horowitz B
    Dev Biol Stand; 1991; 75():43-52. PubMed ID: 1794631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preparation of human albumin from hemolysed blood from frozen placental extracts. I. Technique for preparation and quality of the product].
    Liautaud J; Pla J; Debrus A; Gattel P; Plan R; Peyron L
    Dev Biol Stand; 1974; 27():107-17. PubMed ID: 4142768
    [No Abstract]   [Full Text] [Related]  

  • 20. The human immunodeficiency virus type 1 (HIV-1) vif protein is located in the cytoplasm of infected cells and its effect on viral replication is equivalent in HIV-2.
    Michaels FH; Hattori N; Gallo RC; Franchini G
    AIDS Res Hum Retroviruses; 1993 Oct; 9(10):1025-30. PubMed ID: 8280477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.